首页> 美国卫生研究院文献>American Health Drug Benefits >Assessing the Level of Patient-Specific Treatment Recommendations in Clinical Practice Guidelines for Hemodialysis Vascular Access in the United States
【2h】

Assessing the Level of Patient-Specific Treatment Recommendations in Clinical Practice Guidelines for Hemodialysis Vascular Access in the United States

机译:在美国血液透析血管通路临床实践指南中评估患者特定治疗建议的水平

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundHemodialysis is a procedure that requires efficient removal and return of blood to a patient's body. Despite being a life-sustaining process, hemodialysis is associated with morbidity, mortality, and high societal costs. A significant part of the financial costs to patients and society at large can be attributed to vascular access dysfunction. The cornerstone to efficient hemodialysis is a well-functioning vascular access that simultaneously allows efficient blood flow for dialysis and easy cannulation. It is hypothesized that the poor health outcomes associated with vascular access dysfunction can be improved by paying closer attention to patient-specific factors in clinical guidelines for hemodialysis vascular access. This may require a shift to a more patient-centered approach to vascular access management.
机译:背景技术血液透析是需要有效地去除血液并将血液返回到患者体内的过程。尽管是维持生命的过程,但血液透析与发病率,死亡率和高社会成本有关。对患者和整个社会来说,很大一部分财务费用可归因于血管通路功能障碍。有效血液透析的基石是功能良好的血管通路,该通路同时允许有效的血液流动进行透析并易于插管。假设通过在血液透析血管通路临床指南中密切关注患者特定因素,可以改善与血管通路功能障碍相关的不良健康结果。这可能需要转向以患者为中心的血管通路管理方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号